“Skin Autofluorescence Cannot Serve as a Surrogate Marker for Diabetes Despite Its Correlation with Advanced Glycation End Products”

https://pubmed.ncbi.nlm.nih.gov/38116483

The study found that while skin autofluorescence (SAF) can indicate more accumulation of advanced glycation end products (AGE) in diabetes patients compared to the nondiabetic population, it cannot be confirmed as a valid surrogate marker for diabetes due to the influence of metabolic load and high BMI on SAF levels.